ABCSG 18 Summary

Randomized, doubleblind, placebo-controlled, multi-center phase-3-study to determine the treatment effect of denosumab in subjects with non-metastatic breast cancer receiving non-steroidal aromatase inhibitor therapy.

Start: 11/2006
Coordinating investigator: Gnant, Michael; Vienna
Sample size 3.400
Design:
(Click to enlarge)
ABCSG-18 Design